REQUEST A DEMO
Total
USD $0.00
Search more companies

Piramal Pharma Ltd. (India)

Main Activities: All Other Chemical Product and Preparation Manufacturing
Full name: Piramal Pharma Ltd. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The Company is primarily engaged, directly and indirectly (i) in the business of contract development and organizationservices, ranging from discovery clinical development to commercial manufacturing of active pharmaceutical ingredients,formulations; (ii) in the business of manufacturing, selling and distribution of complex hospital generics includinginhalation anesthesia injectable anaesthesia, intrathecal spasticity and pain management and select antibiotics; and (iii)developing and marketing of consumer healthcare products.
In 2020 :
-The Company was incorporated on March 4, 2020.
-Acquired pharmaceutical business from PEL.
-The Company shares was listed on bombay stock exchange on October 19, 2020.
In 2021 :
-Acquisition of HPPL.
-Acquisition of minority stake in Yapan Bio Private Limited.
In 2024:The Company was listed on Metroploitan Stock Exchange on May 16, 2024.

Headquarters
Agastya Corporate Park Ground Floor Piramal Ananta Opposite Fire Brigadekamani Junction Lbs Marg Kurla West Mumbai In-Mh In 400070
Mumbai; Maharashtra; Postal Code: 400070

Contact Details: Purchase the Piramal Pharma Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Piramal Pharma Ltd. report to view the information.
Outstanding Shares:
Purchase the Piramal Pharma Ltd. report to view the information.
Registered Capital:
Purchase the Piramal Pharma Ltd. report to view the information.
Financial Auditors:
Purchase the Piramal Pharma Ltd. report to view the information.
Incorporation Date:
March 04, 2020
Key Executives
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
34.95%
Purchase this report to view the information.
31.73%
Purchase this report to view the information.
13.29%
Purchase this report to view the information.
11.21%
Purchase this report to view the information.
5.78%
Subsidiaries
Ash Stevens Llc
100%
Piramal Pharma Ii Private Limited
100%
Abbvie Therapeutics India Private Limited
49%
Company Performance
Financial values in the chart are available after Piramal Pharma Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
11.57%
Total operating revenue
11.57%
Operating profit (EBIT)
N/A
EBITDA
54.54%
Net Profit (Loss) for the Period
1.71%
Total equity
10.86%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
0.77%
Return on Equity (ROE)
1.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?